Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer

详细信息    查看全文

• 作者：M.N. Duma (1)
  S. Kampfer (1)
  T. Schuster (2)
  C. Winkler (1)
  H. Geinitz (1)
  
• 关键词：Radiotherapy ; image ; guided ; Head and neck neoplasms ; Helical tomotherapy ; Intensity ; modulated radiotherapy ; Adaptive radiotherapy ; Bildgesteuerte Strahlentherapie ; Kopf ; Hals ; Neoplasien ; Helikale Tomotherapie ; Intensit?tsmodulierte Strahlentherapie ; Adaptive Strahlentherapie
• 刊名：Strahlentherapie und Onkologie
• 出版年：2012
• 出版时间：March 2012
• 年：2012
• 卷：188
• 期：3
• 页码：243-247
• 全文大小：301 KB
• 参考文献：1. Ahn PH, Chen CC, Ahn AI et al (2011) Adaptive planning in intensity-modulated radiation therapy for head and neck cancers: single-institution experience and clinical implications. Int J Radiat Oncol Biol Phys 80:677-85 CrossRef
  2. Barker JL Jr, Garden AS, Ang KK et al (2004) Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 59:960-70 CrossRef
  3. Boda-Heggemann J, Lohr F, Wenz F et al (2011) kV cone-beam CT-based IGRT: a clinical review. Strahlenther Onkol 187:284-91 CrossRef
  4. Budach W, Bolke E, Fietkau R et al (2011) Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial. Strahlenther Onkol 187:449-60 CrossRef
  5. Burman C, Kutcher GJ, Emami B, Goitein M (1991) Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21:123-35 CrossRef
  6. Castadot P, Lee JA, Geets X, Gregoire V (2010) Adaptive radiotherapy of head and neck cancer. Semin Radiat Oncol 20:84-3 CrossRef
  7. Chao KS, Wippold FJ, Ozyigit G et al (2002) Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 53:1174-184 CrossRef
  8. Deasy JO, Blanco AI, Clark VH (2003) CERR: a computational environment for radiotherapy research. Med Phys 30:979-85 CrossRef
  9. Duma MN, Kampfer S, Wilkens JJ et al (2010) Comparative analysis of an image-guided versus a non-image-guided setup approach in terms of delivered dose to the parotid glands in head-and-neck cancer IMRT. Int J Radiat Oncol Biol Phys 77:1266-273 CrossRef
  10. Farrag A, Voordeckers M, Tournel K et al (2010) Pattern of failure after helical tomotherapy in head and neck cancer. Strahlenther Onkol 186:511-16 CrossRef
  11. Geets X, Tomsej M, Lee JA et al (2007) Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy. Radiother Oncol 85:105-15 CrossRef
  12. Gregoire V, Eisbruch A, Hamoir M, Levendag P (2006) Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 79:15-0 CrossRef
  13. Hansen EK, Bucci MK, Quivey JM et al (2006) Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 64:355-62 CrossRef
  14. Kreppel M, Drebber U, Eich HT et al (2011) Combined-modality treatment in advanced oral squamous cell carcinoma: primary surgery followed by adjuvant concomitant radiochemotherapy. Strahlenther Onkol 187:555-60 CrossRef
  15. Lee C, Langen KM, Lu W et al (2008) Evaluation of geometric changes of parotid glands during head and neck cancer radiotherapy using daily MVCT and automatic deformable registration. Radiother Oncol 89:81-8 CrossRef
  16. Rancati T, Schwarz M, Allen AM et al (2010) Radiation dose-volume effects in the larynx and pharynx. Int J Radiat Oncol Biol Phys 76:64-9 CrossRef
  17. Robar JL, Day A, Clancey J et al (2007) Spatial and dosimetric variability of organs at risk in head-and-neck intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 68:1121-130 CrossRef
  18. Sterzing F, Herfarth K, Debus J (2007) IGRT with helical tomotherapy-effort and benefit in clinical routine. Strahlenther Onkol 183(2):35-7 CrossRef
  19. Stock M, Dorr W, Stromberger C et al (2010) Investigations on parotid gland recovery after IMRT in head and neck tumor patients. Strahlenther Onkol 186:665-71 CrossRef
  20. Vasquez Osorio EM, Hoogeman MS, Al-Mamgani A et al (2008) Local anatomic changes in parotid and submandibular glands during radiotherapy for oropharynx cancer and correlation with dose, studied in detail with nonrigid registration. Int J Radiat Oncol Biol Phys 70:875-82 CrossRef
  21. Welsh JS, Lock M, Harari PM et al (2006) Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapy. Technol Cancer Res Treat 5:465-79
  22. Wu Q, Chi Y, Chen PY et al (2009) Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys 75:924-32 CrossRef
  
• 作者单位：M.N. Duma (1)
  S. Kampfer (1)
  T. Schuster (2)
  C. Winkler (1)
  H. Geinitz (1)
  
  1. Department of Radiation Oncology, Technische Universit?t München, Klinikum rechts der Isar, Ismaninger Str. 22, 81675, Munich, Germany
  2. Institute of Medical Statistics and Epidemiology, Technische Universit?t München, Klinikum rechts der Isar, Munich, Germany
  
• ISSN：1439-099X

文摘

Purpose The goal of the present study was to assess the frequency and impact of replanning triggered solely by soft tissue changes observed on the daily setup mega-voltage CT (MVCT) in head and neck cancer (H&N) helical tomotherapy (HT). Material and methods A total of 11 patients underwent adaptive radiotherapy (ART) using MVCT. Preconditions were a soft tissue change >-.5?cm and a tight mask. The dose–volume histograms (DVHs) derived from the initial planning kVCT (inPlan), the recalculated DVHs of the fraction (fx) when replanning was decided (actSit) and the DVHs of the new plan (adaptPlan) were compared. Assessed were the following: maximum dose (Dmax), minimum dose (Dmin), and mean dose (Dmean) to the planning target volume (PTV) normalized to the prescribed dose; the Dmean/fx to the parotid glands (PG), oral cavity (OC), and larynx (Lx); and the Dmax/fx to the spinal cord (SC) in Gy/fx. Results No patient had palpable soft tissue changes. The median weight loss at the moment of replanning was 2.3?kg. The median PTV Dmean was 100% for inPlan, 103% for actSit, and 100% for adaptPlan. The PTV was always covered by the prescribed dose. A statistically significant increase was noted for all organs at risk (OAR) in the actSit. The Dmean to the Lx, the Dmean to the OC and the Dmax to the SC were statistically better in the adaptPlan. No statistically significant improvement was achieved by ART for the PGs. No significant correlations between weight and volume loss or between the volume changes of the organs to each other were observed, except a strong positive correlation of the shrinkage of the PGs (ρ---.77, p--.005). Conclusion Soft tissue shrinkage without clinical palpable changes will not affect the coverage of the PTV, but translates into a higher delivered dose to the PTV itself and the normal tissue outside the PTV. The gain by ART in individual patients—especially in patients who receive doses close to the tolerance doses of the OAR—could be substantial.